{
  "scores": {
    "rubric_version": "v3.0-2025-10-14",
    "items": {
      "Title": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Trial_Design": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Participants": {
        "score": 1,
        "evidence": "We reviewed 330 patients who received perioperative TPE between September 2012 and September 2017."
      },
      "Intervention": {
        "score": 2,
        "evidence": "24 patients received TPE for HIT before anticipated heparin use for CPB."
      },
      "Objective": {
        "score": 1,
        "evidence": "We hypothesized that TPE with heparin re-exposure will not lead to HIT-related thromboembolic events, bleeding, or increased mortality after cardiac surgery with CPB."
      },
      "Method_Outcome": {
        "score": 1,
        "evidence": "Thromboembolic events (TE) occurred in 3 patients within 7 days of surgery; of those, two were possibly HIT-related."
      },
      "Randomisation_Allocation": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Blinding": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Number_Randomised": {
        "score": 1,
        "evidence": "24 patients received TPE for HIT before anticipated heparin use for CPB."
      },
      "Number_Analysed": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Result_Outcome": {
        "score": 2,
        "evidence": "Three patients (12.5%) died within 30 days after surgery but none of the deaths were considered HIT-related."
      },
      "Harms": {
        "score": 1,
        "evidence": "Thromboembolic events (TE) occurred in 3 patients within 7 days of surgery; of those, two were possibly HIT-related."
      },
      "Trial_Registration": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Funding": {
        "score": 0,
        "evidence": "Not reported"
      }
    },
    "total_score": 9,
    "max_score": 25
  },
  "model": "gpt-4o"
}